AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Long-Term-Assets" stands at 84.52 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of AstraZeneca PLC's third quarter, the item "Total Long Term Assets" stands at 84.52 Billion USD. This represents an increase of 1.24 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 4.64 percent compared to the value the year prior.
The 1 year change in percent is 4.64.
The 3 year change in percent is 13.99.
The 5 year change in percent is 83.83.
The 10 year change in percent is 106.54.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Assets | 317,433,206,677.55 |
![]() | Novartis AG - Total Long Term Assets | 255,096,620,580.91 |